Literature DB >> 31292644

Association between metabolic syndrome and knee structural change on MRI.

Feng Pan1, Jing Tian1, Siti Maisarah Mattap1, Flavia Cicuttini2, Graeme Jones1.   

Abstract

OBJECTIVE: To examine the association of metabolic syndrome (MetS) and its components with knee cartilage volume loss and bone marrow lesion (BML) change.
METHODS: Longitudinal data on 435 participants from a population-based cohort study were analysed. Blood pressure, glucose, triglycerides and high-density lipoprotein (HDL) were collected. MetS was defined based on the National Cholesterol Education Program-Adult Treatment Panel III criteria. MRI of the right knee was performed to measure cartilage volume and BML. Radiographic knee OA was assessed by X-ray and graded using the Altman atlas for osteophytes and joint space narrowing.
RESULTS: Thirty-two percent of participants had MetS and 60% had radiographic knee OA. In multivariable analysis, the following were independently associated with medial tibial cartilage volume loss: MetS, β = -0.30%; central obesity, β = -0.26%; and low HDL, β = -0.25% per annum. MetS, hypertriglyceridaemia and low HDL were also associated with higher risk of BML size increase in the medial compartment (MetS: relative risk 1.72, 95% CI 1.22, 2.43; hypertriglyceridaemia: relative risk 1.43, 95% CI 1.01, 2.02; low HDL: relative risk 1.67, 95% CI 1.18, 2.36). After further adjustment for central obesity or BMI, MetS and low HDL remained statistically significant for medial tibial cartilage volume loss and BML size increase. The number of components of MetS correlated with greater cartilage volume loss and BML size increase (both P for trend <0.05). There were no statistically significant associations in the lateral compartment.
CONCLUSION: MetS and low HDL are associated with medial compartment cartilage volume loss and BML size increase, suggesting that targeting these factors has the potential to prevent or slow knee structural change.
© The Author(s) 2019. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  MRI; knee; metabolic syndrome; osteoarthritis; structure

Year:  2020        PMID: 31292644     DOI: 10.1093/rheumatology/kez266

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  5 in total

1.  Investigating the Association of Metabolic Biomarkers With Knee Cartilage Composition and Structural Abnormalities Using MRI: A Pilot Study.

Authors:  Walid Ashmeik; Joe D Baal; Sarah C Foreman; Gabby B Joseph; Emma Bahroos; Misung Han; Roland Krug; Thomas M Link
Journal:  Cartilage       Date:  2020-08-06       Impact factor: 3.117

Review 2.  Adiponectin, May Be a Potential Protective Factor for Obesity-Related Osteoarthritis.

Authors:  Hai Jiang; Yu Pu; Zeng-Hui Li; Wei Liu; Yan Deng; Rui Liang; Xiao-Ming Zhang; Hou-Dong Zuo
Journal:  Diabetes Metab Syndr Obes       Date:  2022-04-27       Impact factor: 3.249

3.  The Impact of Metabolic Syndrome on Quality of Life Among Individuals With Knee Osteoarthritis Living in Egypt.

Authors:  Sara F Samaan; Sara I Taha
Journal:  Clin Med Insights Arthritis Musculoskelet Disord       Date:  2022-05-24

4.  Metabolic Syndrome and Its Effects on Cartilage Degeneration vs Regeneration: A Pilot Study Using Osteoarthritis Biomarkers.

Authors:  Rajath Siddaramanna Onkarappa; Devendra Kumar Chauhan; Biman Saikia; Adil Karim; Rajendra Kumar Kanojia
Journal:  Indian J Orthop       Date:  2020-07-24       Impact factor: 1.251

5.  Fatty Acid-Binding Protein 4 (FABP4) Is Associated with Cartilage Thickness in End-Stage Knee Osteoarthritis.

Authors:  Paul Schadler; Birgit Lohberger; Bettina Thauerer; Martin Faschingbauer; Werner Kullich; Martin Helmut Stradner; Rusmir Husic; Andreas Leithner; Bibiane Steinecker-Frohnwieser
Journal:  Cartilage       Date:  2021-07-05       Impact factor: 3.117

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.